These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 22725849)
1. Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users. Ong MK; Xu H; Zhang L; Azocar F; Ettner SL J Am Geriatr Soc; 2012 Jul; 60(7):1292-7. PubMed ID: 22725849 [TBL] [Abstract][Full Text] [Related]
2. Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders. Ong MK; Zhang L; Xu H; Azocar F; Ettner SL Psychiatr Serv; 2012 Jul; 63(7):637-42. PubMed ID: 22549332 [TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions. Yang HW; Simoni-Wastila L; Zuckerman IH; Stuart B Psychiatr Serv; 2008 Apr; 59(4):384-91. PubMed ID: 18378837 [TBL] [Abstract][Full Text] [Related]
4. The effect of the Medicare Part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications. Chen YC; Kreling DH Res Social Adm Pharm; 2014; 10(2):438-47. PubMed ID: 23880428 [TBL] [Abstract][Full Text] [Related]
5. Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries. Maust DT; Lin LA; Goldstick JE; Haffajee RL; Brownlee R; Bohnert ASB JAMA Netw Open; 2020 Apr; 3(4):e202051. PubMed ID: 32242907 [TBL] [Abstract][Full Text] [Related]
6. The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Chen H; Nwangwu A; Aparasu R; Essien E; Sun S; Lee K Psychiatr Serv; 2008 Oct; 59(10):1191-7. PubMed ID: 18832506 [TBL] [Abstract][Full Text] [Related]
7. Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes. Briesacher BA; Soumerai SB; Field TS; Fouayzi H; Gurwitz JH Arch Intern Med; 2010 Apr; 170(8):693-8. PubMed ID: 20421554 [TBL] [Abstract][Full Text] [Related]
8. Consequences of a benzodiazepine discontinuation programme in family practice on psychotropic medication prescription to the participants. Gorgels WJ; Oude Voshaar RC; Mol AJ; van de Lisdonk EH; Mulder J; van den Hoogen H; van Balkom AJ; Breteler MH; Zitman FG Fam Pract; 2007 Oct; 24(5):504-10. PubMed ID: 17644828 [TBL] [Abstract][Full Text] [Related]
9. Psychotropic medication expenditures for community-dwelling elderly persons. Aparasu R; Mort J; Brandt H Psychiatr Serv; 2003 May; 54(5):739-42. PubMed ID: 12719508 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016. Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703 [TBL] [Abstract][Full Text] [Related]
11. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018. Klau J; Bernardo CO; Gonzalez-Chica DA; Raven M; Jureidini J Aust N Z J Psychiatry; 2022 Nov; 56(11):1477-1490. PubMed ID: 34963342 [TBL] [Abstract][Full Text] [Related]
12. National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009. Wu CH; Wang CC; Katz AJ; Farley J J Anxiety Disord; 2013 Mar; 27(2):163-70. PubMed ID: 23428605 [TBL] [Abstract][Full Text] [Related]
13. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014. Maust DT; Kim HM; Chiang C; Kales HC JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856 [TBL] [Abstract][Full Text] [Related]
14. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study. Carico R; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Suda KJ; Stroupe K; Hanlon JT; Good CB; Fine MJ; Gellad WF Ann Intern Med; 2018 Nov; 169(9):593-601. PubMed ID: 30304353 [TBL] [Abstract][Full Text] [Related]
15. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. Hernandez I; He M; Brooks MM; Zhang Y JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080 [TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine use in general practice--is it a problem? North DA; McAvoy BR; Powell AM N Z Med J; 1992 Jul; 105(938):287-9. PubMed ID: 1495662 [TBL] [Abstract][Full Text] [Related]
17. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Westbury JL; Gee P; Ling T; Brown DT; Franks KH; Bindoff I; Bindoff A; Peterson GM Med J Aust; 2018 May; 208(9):398-403. PubMed ID: 29747564 [TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine use among the elderly in the community. Kirby M; Denihan A; Bruce I; Radic A; Coakley D; Lawlor BA Int J Geriatr Psychiatry; 1999 Apr; 14(4):280-4. PubMed ID: 10340189 [TBL] [Abstract][Full Text] [Related]
20. Coprescribing of opioids and psychotropic medications among Medicare-enrolled older adults on long-term opioid therapy. Maharjan S; Kertesz SG; Bhattacharya K; Markland A; McGwin G; Yang Y; Bentley JP; Ramachandran S J Am Pharm Assoc (2003); 2023; 63(6):1753-1760.e5. PubMed ID: 37633452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]